Literature DB >> 16954719

Reciprocity and post-trial access for participants in antiretroviral therapy trials.

Maria Merritt, Christine Grady.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16954719     DOI: 10.1097/01.aids.0000244197.88134.45

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  11 in total

1.  Incidental findings and ancillary-care obligations.

Authors:  Henry S Richardson
Journal:  J Law Med Ethics       Date:  2008       Impact factor: 1.718

2.  Demographic and health surveillance: longitudinal ethical considerations.

Authors:  Margaret Carrel; Stuart Rennie
Journal:  Bull World Health Organ       Date:  2008-08       Impact factor: 9.408

3.  Post-trial access to antiretrovirals: who owes what to whom?

Authors:  Joseph Millum
Journal:  Bioethics       Date:  2011-03       Impact factor: 1.898

4.  An Ethical Imperative to Ensure Uninterrupted HIV Care Following Therapeutic Trials: One Experience in Peru.

Authors:  Katherine Garcia-Rosales; Karin Sosa Barbaran; Jessica Rios; Delia Pinto-Santini; Maria Del Rosario Leon; Jorge A Gallardo-Cartagena; John MacRae; Mey Leon; Javier Valencia-Huamaní; Esmelda Montalban; Pedro Gonzales; Ann Duerr; Javier R Lama; Rachel Bender Ignacio
Journal:  AIDS Patient Care STDS       Date:  2022-06       Impact factor: 5.944

5.  Gradations of researchers' obligation to provide ancillary care for HIV/AIDS in developing countries.

Authors:  Henry S Richardson
Journal:  Am J Public Health       Date:  2007-09-27       Impact factor: 9.308

6.  Access to medications and medical care after participation in HIV clinical trials: a systematic review of trial protocols and informed consent documents.

Authors:  Andrea L Ciaranello; Rochelle P Walensky; Paul E Sax; Yuchiao Chang; Kenneth A Freedberg; Joel S Weissman
Journal:  HIV Clin Trials       Date:  2009 Jan-Feb

7.  Subjects' views of obligations to ensure post-trial access to drugs, care and information: qualitative results from the Experiences of Participants in Clinical Trials (EPIC) study.

Authors:  N Sofaer; C Thiessen; S D Goold; J Ballou; K A Getz; G Koski; R A Krueger; J S Weissman
Journal:  J Med Ethics       Date:  2009-03       Impact factor: 2.903

8.  Reasons Why Post-Trial Access to Trial Drugs Should, or Need not be Ensured to Research Participants: A Systematic Review.

Authors:  Neema Sofaer; Daniel Strech
Journal:  Public Health Ethics       Date:  2011-07-11       Impact factor: 1.940

Review 9.  The clinical investigator-subject relationship: a contextual approach.

Authors:  David B Resnik
Journal:  Philos Ethics Humanit Med       Date:  2009-12-03       Impact factor: 2.464

10.  The ancillary-care obligations of medical researchers working in developing countries.

Authors: 
Journal:  PLoS Med       Date:  2008-05-20       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.